Redeye ser fortsatt positivt på Irlab efter att ha tagit del av företagets Q3-rapport, som kom in so...
Raketech just released a decent Q3 report, and a start of the fourth quarter in-line with our foreca...
Redeye provides an update on M.O.B.A. following its strong Q2 2022 report.
Redeye strengthens its positive view on Vertiseit following a solid Q3, showing significant margin i...
Redeye retains its positive view of Speqta following a solid Q3 report.
Redeye is surprised by Vitec announcing a directed share issue.
Redeye takes a positive stance towards Hanza following a solid Q3 report, new ambitious financial ta...
Redeye decreases its fair value range for aXichem after reviewing the case and making significant ch...
Safe Lane Gaming publicerade den 9 november år 2022 bolagets delårsrapport för tredje kvartalet 2022...
RU equipment sales to fall off, aftermarket stronger SEK 321m VCE payment added as a one-off We expe...
EBITDA SEK 713m vs. ABGSCe SEK 718m Renewable energy project portfolio of 2,600 MW Conference call a...
Following a successful exhibition at the Supply Side West trade show in Las Vegas, US, last week, Ee...
Redeye leaves its comments on Xspray Pharma’s Q3 2022 report.
Rapportkommentar Egetis presenterade under gårdagen sin Q3-rapport.
Fantasma Games publicerade idag, den 9e november 2022, bolagets delårsrapport för det tredje kvartal...
Sammantaget har det varit ett händelserikt kvartal.
Redeye comments on Arise’s Q3 report, which was the strongest quarter in the company’s history.
Redeye comments on Freemelt’s Q3 results, which came in lower than expected in terms of sales, while...
Redeye will consider raising its near-term estimates on the back of this Q3 report, which crushed ou...
Orderingången i Q3 var stark och efterfrågan är fortsatt god.
